Y Schenk

1.0k total citations
14 papers, 786 citations indexed

About

Y Schenk is a scholar working on Rheumatology, Genetics and Neurology. According to data from OpenAlex, Y Schenk has authored 14 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 3 papers in Genetics and 3 papers in Neurology. Recurrent topics in Y Schenk's work include Rheumatoid Arthritis Research and Therapies (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Y Schenk is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Peripheral Neuropathies and Disorders (3 papers). Y Schenk collaborates with scholars based in Netherlands, Germany and United States. Y Schenk's co-authors include Johannes W. G. Jacobs, J. W. J. Bijlsma, Suzanne Verstappen, M. J. van der Veen, E. J. ter Borg, A H M Heurkens, A. A. M. Blaauw, J.W. Bijlsma, Rinie Geenen and Marianne B. Kool and has published in prestigious journals such as Annals of the Rheumatic Diseases, Thorax and Lara D. Veeken.

In The Last Decade

Y Schenk

14 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y Schenk Netherlands	9	585	246	134	110	94	14	786
David Walker United Kingdom	11	465 0.8×	239 1.0×	141 1.1×	79 0.7×	43 0.5×	53	753
G. Armstrong United Kingdom	12	356 0.6×	142 0.6×	161 1.2×	127 1.2×	28 0.3×	25	691
Herman L. M. Brus Netherlands	9	318 0.5×	140 0.6×	73 0.5×	59 0.5×	42 0.4×	12	456
K Pugner United Kingdom	6	477 0.8×	161 0.7×	42 0.3×	64 0.6×	170 1.8×	13	756
T. Uhlig Norway	11	536 0.9×	218 0.9×	33 0.2×	63 0.6×	78 0.8×	18	707
Erik Rødevand Norway	15	1.0k 1.7×	451 1.8×	98 0.7×	98 0.9×	53 0.6×	31	1.2k
Irazú Contreras-Yáñez Mexico	13	379 0.6×	104 0.4×	109 0.8×	69 0.6×	41 0.4×	74	572
Liza Takiya United States	15	267 0.5×	137 0.6×	70 0.5×	52 0.5×	116 1.2×	47	888
Penelope Baker Canada	6	315 0.5×	170 0.7×	63 0.5×	86 0.8×	24 0.3×	14	531
Stefania Gasparini Italy	13	452 0.8×	222 0.9×	22 0.2×	53 0.5×	119 1.3×	18	665

Countries citing papers authored by Y Schenk

Since Specialization

Citations

This map shows the geographic impact of Y Schenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Schenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Schenk more than expected).

Fields of papers citing papers by Y Schenk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Schenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Schenk. The network helps show where Y Schenk may publish in the future.

Co-authorship network of co-authors of Y Schenk

This figure shows the co-authorship network connecting the top 25 collaborators of Y Schenk. A scholar is included among the top collaborators of Y Schenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Schenk. Y Schenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rossato, Marzia, Ruth Fritsch‐Stork, Y Schenk, et al.. (2016). Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?. Arthritis Research & Therapy. 18(1). 189–189. 28 indexed citations

Geenen, Rinie, et al.. (2014). The separate impact of tight control schemes and disease activity on quality of life in patients with early rheumatoid arthritis: results from the CAMERA trials.. PubMed. 32(3). 369–76. 7 indexed citations

Hofland, Regina W., Steven Thijsen, M.A.M.T. Verhagen, Y Schenk, & Ailko Bossink. (2013). Tuberculosis during TNF-α inhibitor therapy, despite screening: Table 1. Thorax. 68(11). 1079–1080. 9 indexed citations

Ton, Evelien, Marije F. Bakker, Suzanne Verstappen, et al.. (2011). Look Beyond the Disease Activity Score of 28 Joints (DAS28): Tender Points Influence the DAS28 in Patients with Rheumatoid Arthritis. The Journal of Rheumatology. 39(1). 22–27. 46 indexed citations

Kool, Marianne B., Henriët van Middendorp, Mark A. Lumley, et al.. (2010). Lack of understanding in fibromyalgia and rheumatoid arthritis: the Illness Invalidation Inventory (3*I). Annals of the Rheumatic Diseases. 69(11). 1990–1995. 106 indexed citations

Verstappen, Suzanne, Johannes W. G. Jacobs, M. J. van der Veen, et al.. (2007). Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Annals of the Rheumatic Diseases. 66(11). 1443–1449. 417 indexed citations

Friedrich, Reinhard E., et al.. (2005). Diagnosis, treatment and follow-up control in 124 patients with basal cell carcinoma of the maxillofacial region treated from 1992 to 1997.. PubMed. 25(3A). 1693–7. 8 indexed citations

Verstappen, Suzanne, Annelies Boonen, J. W. J. Bijlsma, et al.. (2004). Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions. Lara D. Veeken. 44(2). 202–206. 43 indexed citations

Jaarsveld, Cornelia H.M. van, Johannes W G Jacobs, M. J. Van Der Veen, et al.. (2000). Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. Annals of the Rheumatic Diseases. 59(6). 468–477. 69 indexed citations

10.

Jaarsveld, Cornelia H.M. van, Z N Jahangier, J. W. G. Jacobs, et al.. (2000). Toxicity of anti‐rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Lara D. Veeken. 39(12). 1374–1382. 34 indexed citations

11.

Jaarsveld, Cornelia H.M. van, et al.. (1998). Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. UCL Discovery (University College London). 3 indexed citations

12.

Heide, Aǵnes van der, J Jacobs, Y Schenk, & J.W. Bijlsma. (1994). Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis.. PubMed. 21(12). 2195–9. 7 indexed citations

13.

Schenk, Y, et al.. (1986). Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis.. PubMed. 5(4). 499–504. 6 indexed citations

14.

Schenk, Y, et al.. (1982). A comparison of ranitidine and cimetidine in the treatment of gastric ulcer. A two-centre study.. PubMed. 25(9). 308–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact